Loading clinical trials...
Loading clinical trials...
This is a single institution, observational research study in which patients are observed using DWI/DCE MRI imaging before and after receiving neoadjuvant anti-HER2 therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Washington
NCT06949410 · Breast Cancer, HER2-positive Breast Cancer
NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more
NCT04030507 · Breast Cancer, HER2-positive Breast Cancer, and more
NCT04886531 · Breast Cancer, HER2-positive Breast Cancer, and more
NCT04585750 · Advanced Solid Tumor, Advanced Malignant Neoplasm, and more
Seattle Cancer Care Alliance
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions